These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10914056)

  • 21. Ocular hemorrhage secondary to thioguanine-associated veno-occlusive disease in a child with acute lymphoblastic leukemia in delayed intensification.
    Bhunia N; Yeager ND; Colace SI; Buzzaco D; Bajwa RPS
    Pediatr Transplant; 2020 Feb; 24(1):e13638. PubMed ID: 31840375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia.
    Halonen P; Salo MK; Mäkipernaa A
    J Pediatr; 2001 Mar; 138(3):428-31. PubMed ID: 11241057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
    Broxson EH; Dole M; Wong R; Laya BF; Stork L
    Pediatr Blood Cancer; 2005 Mar; 44(3):226-31. PubMed ID: 15503293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis and cytomegalovirus in patients with acute leukemia].
    Marés Bermúdez J; Plaja Román P; Calico I; Javier Manchón G; Ortega Aramburu JJ
    Sangre (Barc); 1988 Jun; 33(3):202-5. PubMed ID: 2845589
    [No Abstract]   [Full Text] [Related]  

  • 25. DNA-TG and risk of sinusoidal obstruction syndrome in childhood acute lymphoblastic leukemia.
    Toksvang LN; Grell K; Nielsen SN; Nersting J; Murdy D; Moorman AV; Vora A; Schmiegelow K
    Leukemia; 2022 Feb; 36(2):555-557. PubMed ID: 34535761
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered metabolism of tacrolimus in hepatic veno-occlusive disease.
    Mori T; Shimizu T; Yamazaki R; Nakazato T; Ikeda Y; Okamoto S
    Transpl Int; 2005 Oct; 18(10):1215-7. PubMed ID: 16162110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
    Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
    Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venoocclusive disease due to chemotherapy for pediatric acute lymphoblastic leukemia is associated with increased levels of plasminogen-activator inhibitor-1.
    Mauro M; Saggiorato G; Sartori MT; Gallo G; De Bortoli M; Bonetti E; Zaccaron A; Vitale V; Balter R; Chinello M; Cesaro S
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26963. PubMed ID: 29350496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
    Kaya Z; Gursel T; Bakkaloglu SA; Kocak U; Atasever T; Oktar SO
    Pediatr Hematol Oncol; 2007 Jun; 24(4):257-67. PubMed ID: 17613868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.
    Kebriaei P; Cutler C; de Lima M; Giralt S; Lee SJ; Marks D; Merchant A; Stock W; van Besien K; Stelljes M
    Bone Marrow Transplant; 2018 Apr; 53(4):449-456. PubMed ID: 29330398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute lymphoblastic leukemia in a child with Wilson disease.
    Yüce A; Koçak N; Yetgin S; Ozen H; Gürakan F; Yenicesu I
    Turk J Pediatr; 2000; 42(3):256-7. PubMed ID: 11105631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis.
    O'Brien MM; Lee-Kim Y; George TI; McClain KL; Twist CJ; Jeng M
    Pediatr Blood Cancer; 2008 Feb; 50(2):381-3. PubMed ID: 16856156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
    Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
    Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
    Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
    Tolar J; Bostrom BC; La MK; Sather HN
    Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
    Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
    Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
    [No Abstract]   [Full Text] [Related]  

  • 38. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
    Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
    Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Veno-occlusive liver disease induced by Senecio vulgaris toxicity].
    Vilar JH; García M; Cabrera P
    Gastroenterol Hepatol; 2000; 23(6):285-6. PubMed ID: 15324624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
    Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
    Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.